Patient Identification<\/h1><\/div><\/div><\/div><\/div><\/div>Target Patient Population (NYHA III-IV)<\/h2><\/div>Previous myocardial infarction (90 days or more) with scar (ischemic)\u200b<\/p>\n<\/div><\/div><\/div>
![\"Target](\"https:\/\/bioventrix.com\/wp-content\/uploads\/2022\/11\/target-population.png\")
<\/a><\/span><\/div><\/div><\/div><\/i><\/i><\/span>Scar<\/span><\/a><\/h4><\/div>\n\n- Anteroseptal, apical, and\/or anterolateral region\u200b<\/li>\n
- Discrete acontractile (akinetic and\/or dyskinetic)\u200b<\/li>\n
- Transmural (>50%)\u200b<\/li>\n<\/ul>\n<\/div><\/div><\/div>
Target Patient Population (NYHA III-IV)<\/h2><\/div>Previous myocardial infarction (90 days or more) with scar (ischemic)\u200b<\/p>\n<\/div><\/div><\/div>
<\/a><\/span><\/div><\/div><\/div><\/i><\/i><\/span>Scar<\/span><\/a><\/h4><\/div>\n\n- Anteroseptal, apical, and\/or anterolateral region\u200b<\/li>\n
- Discrete acontractile (akinetic and\/or dyskinetic)\u200b<\/li>\n
- Transmural (>50%)\u200b<\/li>\n<\/ul>\n<\/div><\/div><\/div>
Previous myocardial infarction (90 days or more) with scar (ischemic)\u200b<\/p>\n<\/div><\/div><\/div>
<\/a><\/span><\/div><\/div><\/div><\/i><\/i><\/span>Scar<\/span><\/a><\/h4><\/div>\n\n- Anteroseptal, apical, and\/or anterolateral region\u200b<\/li>\n
- Discrete acontractile (akinetic and\/or dyskinetic)\u200b<\/li>\n
- Transmural (>50%)\u200b<\/li>\n<\/ul>\n<\/div><\/div><\/div>
\n
- \n
- Anteroseptal, apical, and\/or anterolateral region\u200b<\/li>\n
- Discrete acontractile (akinetic and\/or dyskinetic)\u200b<\/li>\n
- Transmural (>50%)\u200b<\/li>\n<\/ul>\n<\/div><\/div><\/div>